{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:11:00Z","timestamp":1792426260276,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872284"],"award-info":[{"award-number":["81872284"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.trsl.2023.03.003","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T01:18:49Z","timestamp":1679793529000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma"],"prefix":"10.1016","volume":"259","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-2624","authenticated-orcid":false,"given":"Feng","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaochang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2023.03.003_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood-brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.trsl.2023.03.003_bib0002","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/cmi.2017.159","article-title":"Cellular origin of glioblastoma and its implication in precision therapy","volume":"15","author":"Yao","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.trsl.2023.03.003_bib0003","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41551-020-00621-9","article-title":"A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma","volume":"5","author":"Wong","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.trsl.2023.03.003_bib0004","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"New Engl J Med"},{"key":"10.1016\/j.trsl.2023.03.003_bib0005","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/neuonc\/nox182","article-title":"Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma","volume":"20","author":"Bielamowicz","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.trsl.2023.03.003_bib0006","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1172\/JCI131246","article-title":"Tandem CAR T cells targeting HER2 and IL13Ralpha2 mitigate tumor antigen escape","volume":"129","author":"Hegde","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2023.03.003_bib0007","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw2672","article-title":"Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma","volume":"12","author":"Wang","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trsl.2023.03.003_bib0008","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molmed.2012.04.009","article-title":"CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe","volume":"18","author":"Gilham","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.trsl.2023.03.003_bib0009","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41591-020-0827-2","article-title":"Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma","volume":"26","author":"Donovan","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2023.03.003_bib0010","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/neuonc\/noab022","article-title":"Blood-brain barrier alterations in human brain tumors revealed by genome-wide transcriptomic profiling","volume":"23","author":"Schaffenrath","year":"2021","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.trsl.2023.03.003_bib0011","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1158\/2159-8290.CD-11-0284","article-title":"Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors","volume":"2","author":"Vivanco","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.trsl.2023.03.003_bib0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1389203033487289","article-title":"Modulation of cellular function by TAT mediated transduction of full-length proteins","volume":"4","author":"Wadia","year":"2003","journal-title":"Curr Protein Pept Sc"},{"key":"10.1016\/j.trsl.2023.03.003_bib0013","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2174\/1568026616666161222101355","article-title":"Nanocarriers for effective brain drug delivery","volume":"17","author":"Comoglu","year":"2017","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.trsl.2023.03.003_bib0014","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejps.2010.05.003","article-title":"Strategy for effective brain drug delivery","volume":"40","author":"Alam","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.trsl.2023.03.003_bib0015","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biomaterials.2012.09.047","article-title":"Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier","volume":"34","author":"Ja-Young","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.trsl.2023.03.003_bib0016","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2018.03.028","article-title":"RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy","volume":"543","author":"Hua","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.trsl.2023.03.003_bib0017","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1021\/acsnano.7b08172","article-title":"Targeted brain delivery of rabies virus glycoprotein 29-modified deferoxamine-loaded nanoparticles reverses functional deficits in Parkinsonian mice","volume":"12","author":"Linhao","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.trsl.2023.03.003_bib0018","doi-asserted-by":"crossref","first-page":"e62905","DOI":"10.1371\/journal.pone.0062905","article-title":"Targeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson's disease","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2023.03.003_bib0019","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Yang","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.trsl.2023.03.003_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pep.2014.09.001","article-title":"Production and characterization of a fusion peptide derived from the rabies virus glycoprotein (RVG29)","volume":"104","author":"Yang","year":"2014","journal-title":"Protein Expres Purif"},{"key":"10.1016\/j.trsl.2023.03.003_bib0021","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.biomaterials.2011.12.017","article-title":"Target delivery of a gene into the brain using the RVG29-oligoarginine peptide","volume":"33","author":"Cheng","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.trsl.2023.03.003_bib0022","first-page":"529","article-title":"Macrophage membrane-coated nanocarriers co-modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice","volume":"6","author":"Han","year":"2021","journal-title":"Bioact Mater"},{"key":"10.1016\/j.trsl.2023.03.003_bib0023","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1182\/blood.2020008221","article-title":"CD70-specific CAR T-cells have potent activity against acute myeloid leukemia (AML) without HSC toxicity","volume":"138","author":"Sauer","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2023.03.003_bib0024","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/cac2.12201","article-title":"CD70-targeting CAR-T cells have potential activity against CD19-negative B-cell lymphoma","volume":"41","author":"Deng","year":"2021","journal-title":"Cancer Commun"},{"key":"10.1016\/j.trsl.2023.03.003_bib0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/neuonc\/nox116","article-title":"CD70, a novel target of CAR T-cell therapy for gliomas","volume":"20","author":"Linchun","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.trsl.2023.03.003_bib0026","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/ijc.30830","article-title":"Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM","volume":"141","author":"Ge","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trsl.2023.03.003_bib0027","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13045-021-01168-1","article-title":"Targeting the DNA damage response enhances CD70 CAR-T cell therapy for renal carcinoma by activating the cGAS-STING pathway","volume":"14","author":"Feng","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.trsl.2023.03.003_bib0028","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00401-020-02171-5","article-title":"Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource","volume":"140","author":"Smith Kyle","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.trsl.2023.03.003_bib0029","doi-asserted-by":"crossref","first-page":"e3465","DOI":"10.21769\/BioProtoc.3465","article-title":"Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol","volume":"9","author":"Crowe","year":"2019","journal-title":"Bio-Protocol"},{"key":"10.1016\/j.trsl.2023.03.003_bib0030","doi-asserted-by":"crossref","first-page":"z1863","DOI":"10.1126\/scitranslmed.aaz1863","article-title":"Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors","volume":"12","author":"Park Anthony","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trsl.2023.03.003_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119666","article-title":"An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy","volume":"230","author":"Lu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.trsl.2023.03.003_bib0032","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.7150\/thno.43991","article-title":"Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors","volume":"10","author":"Meijia","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.trsl.2023.03.003_bib0033","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman Aaron","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.trsl.2023.03.003_bib0034","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aax0194","article-title":"mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence","volume":"367","author":"Hwang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.trsl.2023.03.003_bib0035","doi-asserted-by":"crossref","first-page":"e1135","DOI":"10.1002\/cti2.1135","article-title":"EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo","volume":"9","author":"Lin","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.trsl.2023.03.003_bib0036","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1158\/0008-5472.CAN-21-0035","article-title":"An oncolytic virus expressing IL15\/IL15Ralpha combined with off-the-shelf EGFR-CAR NK cells targets glioblastoma","volume":"81","author":"Ma","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2023.03.003_bib0037","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s00262-022-03172-x","article-title":"Enhancement of CD70-specific CAR T treatment by IFN-gamma released from oHSV-1-infected glioblastoma","volume":"71","author":"Zhu","year":"2022","journal-title":"Cancer Immunol Immun"},{"key":"10.1016\/j.trsl.2023.03.003_bib0038","doi-asserted-by":"crossref","first-page":"11483","DOI":"10.1038\/srep11483","article-title":"CAR-engineered NK cells targeting wild-type EGFR and EGFRvIII enhance killing of glioblastoma and patient-derived glioblastoma stem cells","volume":"5","author":"Han","year":"2015","journal-title":"Sci Rep UK"},{"key":"10.1016\/j.trsl.2023.03.003_bib0039","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1021\/acsnano.1c09601","article-title":"Rabies virus glycoprotein-mediated transportation and T cell infiltration to brain tumor by magnetoelectric gold yarnballs","volume":"16","author":"Wei","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.trsl.2023.03.003_bib0040","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3389\/fonc.2019.01350","article-title":"CD19 and CD70 dual-target chimeric antigen receptor t-cell therapy for the treatment of relapsed and refractory primary central nervous system diffuse large B-cell lymphoma","volume":"9","author":"Sanfang","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.trsl.2023.03.003_bib0041","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nm.4441","article-title":"CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2023.03.003_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1758835920910347","article-title":"Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release","volume":"12","author":"Liu","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.trsl.2023.03.003_bib0043","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41591-020-0827-2","article-title":"Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma","volume":"26","author":"Donovan Laura","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2023.03.003_bib0044","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.ymthe.2020.09.015","article-title":"CAR T cell therapy for solid tumors: bright future or dark reality?","volume":"28","author":"Wagner","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.trsl.2023.03.003_bib0045","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/cells8080889","article-title":"Application of highly immunocompromised mice for the establishment of patient-derived xenograft (PDX) models","volume":"8","author":"Okada","year":"2019","journal-title":"Cells Basel"},{"key":"10.1016\/j.trsl.2023.03.003_bib0046","doi-asserted-by":"crossref","first-page":"e5981","DOI":"10.7717\/peerj.5981","article-title":"A systematic review of the validity of patient derived xenograft (PDX) models: the implications for translational research and personalised medicine","volume":"6","author":"Collins","year":"2018","journal-title":"Peer J"},{"key":"10.1016\/j.trsl.2023.03.003_bib0047","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41586-022-05126-w","article-title":"RASA2 ablation in T cells boosts antigen sensitivity and long-term function","volume":"609","author":"Julia","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2023.03.003_bib0048","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cmet.2017.06.016","article-title":"Metabolic regulation of T cell longevity and function in tumor immunotherapy","volume":"26","author":"Kishton","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2023.03.003_bib0049","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1749-6632.2009.05126.x","article-title":"Memory CD8+ T cell differentiation","volume":"1183","author":"Obar","year":"2010","journal-title":"Ann NY Acad Sci"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:48:19Z","timestamp":1761828499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524423000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":49,"alternative-id":["S1931524423000543"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2023.03.003","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2023.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}